Most sold healthcare stocks in Q2 2014

See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2014, measured as net reductions in reported share positions from Q1 2014 into Q2 2014. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), ZOETIS INC (ZTS). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−12.3M−9.2M−6.2M−3.1M0.00Net change in reported shares (all institutional filers)PFEMRKLLYZTSUHSCAHTMOBSXSYKILMNDVABKDDGXCRLABBVVRTXDXCMPBHABTWATSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
PFEPFIZER INC-11,195,648-$524.81M056013
MRKMERCK & CO. INC.-4,155,618-$185.51M027014
LLYELI LILLY & CO-1,918,159-$99.22M00606
ZTSZOETIS INC-1,749,629-$42.79M00112
UHSUNIVERSAL HEALTH SERVICES-B-1,564,156-$110.88M00111
CAHCARDINAL HEALTH INC-1,535,832-$107.88M11123
TMOTHERMO FISHER SCIENTIFIC INC-1,351,231-$197.59M02609
BSXBOSTON SCIENTIFIC CORP-1,305,550-$51.80M00203
SYKSTRYKER CORP-1,146,743-$56.74M21306
ILMNILLUMINA INC-1,081,719$90.28M01113
DVADAVITA INC-1,062,744$85.85M03115
BKDBROOKDALE SENIOR LIVING INC-856,298-$29.12M00202
DGXQUEST DIAGNOSTICS INC-503,191-$28.47M01304
CRLCHARLES RIVER LABORATORIES-474,914-$45.14M01203
ABBVABBVIE INC-447,711-$5.36M11317
VRTXVERTEX PHARMACEUTICALS INC-388,561-$27.48M00020
DXCMDEXCOM INC-380,843-$15.75M00010
PBHPRESTIGE CONSUMER HEALTHCARE-335,548-$3.88M00101
ABTABBOTT LABORATORIES-327,482$69.65M326014
WATWATERS CORP-313,904-$41.02M00212
CCRNCROSS COUNTRY HEALTHCARE INC-297,402-$2.75M00101
RDYDR. REDDY'S LABORATORIES-ADR-230,400-$9.44M00101
PODDINSULET CORP-197,700-$10.67M00101
PFMTPERFORMANT FINANCIAL CORP-196,908-$1.63M00101
BRKRBRUKER CORP-191,100-$3.97M00101
ALGNALIGN TECHNOLOGY INC-186,632$19.12M11103
PCRXPACIRA BIOSCIENCES INC-171,500-$12.00M00010
ALNYALNYLAM PHARMACEUTICALS INC-158,700-$10.65M00010
AMNAMN HEALTHCARE SERVICES INC-157,000-$2.26M00101
BIIBBIOGEN INC-155,633-$45.31M21014
EBSEMERGENT BIOSOLUTIONS INC-155,387-$5.63M00101
RVTYREVVITY INC-151,200-$6.51M00101
OMIOWENS & MINOR INC-150,573-$5.63M00101
CHECHEMED CORP-148,437-$8.48M02204
LFCRLIFECORE BIOMEDICAL INC-142,471$1.66M00202
PETSPETMED EXPRESS INC-121,801-$1.51M00101
FOLDAMICUS THERAPEUTICS INC-121,000-$250.00K00010
PACBPACIFIC BIOSCIENCES OF CALIF-105,766-$566.00K00010
SEMSELECT MEDICAL HOLDINGS CORP-93,048-$822.00K00101
FONRFONAR CORP-91,375-$3.15M00101
BCRXBIOCRYST PHARMACEUTICALS INC-90,514-$958.00K00010
ICUIICU MEDICAL INC-86,701-$4.59M00101
UTMDUTAH MEDICAL PRODUCTS INC-81,249-$7.20M01102
MTDMETTLER-TOLEDO INTERNATIONAL-80,154-$18.17M00101
ANIKANIKA THERAPEUTICS INC-75,000-$1.16M00101
HAEHAEMONETICS CORP/MASS-63,826-$1.50M00121
HUMHUMANA INC-63,000-$5.84M10011
ICADICAD INC-59,200-$1.35M00101
MMSIMERIT MEDICAL SYSTEMS INC-57,003-$671.00K00101
TFXTELEFLEX INC-56,095-$9.91M01304

Frequently asked questions about Most sold healthcare stocks in Q2 2014

  • What are the most sold Healthcare stocks in Q2 2014?

    The most sold healthcare stocks in Q2 2014 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2014, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2014?

    Among filers in this sector, net reductions were largest in companies such as PFIZER INC (PFE), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2014).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.